Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05699460 · ClinicalTrials.gov registry record

Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

A clinical trial of Parkinson's Disease and Multiple System Atrophy, sponsored by AskBio.

Active
Registry status
150
Enrollment target
11
Study locations

NCT05699460 is a study of Parkinson's Disease and Multiple System Atrophy that is active but no longer recruiting, run by AskBio. The registered enrollment target is 150 participants, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (77% lower). The trial reports 11 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05699460, a study of Parkinson's Disease and Multiple System Atrophy, is active but no longer recruiting, sponsored by AskBio.

ACTIVE NOT RECRUITING
Registry status
150 participants
Enrollment target
11
Study locations

Study Summary

The objective of this study is to describe disease progression in study participants diagnosed with early Parkinson's Disease or Multiple System Atrophy - Parkinsonian Type up to 18 months as delineated by clinical and biochemical parameters.

Conditions Studied

Parkinson's Disease Multiple System Atrophy Multiple System Atrophy, Parkinson Variant

Interventions

  • OTHER This is an observational study.

Study Locations (11)

Other

  • Specjalistyczna Praktyka Lekarska, Prof. Grzegorz Opala - Katowice
  • Mazowiecki Szpital Bródnowski w Warszawie, Oddział Neurologii - Warsaw
  • Samodzielny Publiczny Szpital Kliniczny im. prof. Witolda Orłowskiego, Oddział Neurologii i Epileptologii - Warsaw

California

  • University of California Irvine - Irvine

Florida

  • Parkinson's Disease and Movement Disorders Center of Boca Raton - Boca Raton

Massachusetts

  • Massachusetts General Hospital - Boston

Michigan

  • Quest Research Institute - Farmington Hills

Ohio

  • Ohio Health Research Institute - Columbus

Oregon

  • OHSU Parkinson Center & Movement Disorders Program - Portland

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-09-29
Est. Completion 2025-11

Sponsor

AskBio

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05699460

The ClinicalTrials.gov registry entry for NCT05699460 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 641-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (77% lower). The listed sponsor is AskBio, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which This is an observational study. is the first listed.

NCT05699460 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Other, California, Florida.

Frequently Asked Questions

What is clinical trial NCT05699460 about?

NCT05699460 is a clinical study titled "Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy". The objective of this study is to describe disease progression in study participants diagnosed with early Parkinson's Disease or Multiple System Atrophy - Parkinsonian Type up to 18 months as delineated by clinical and biochemical parameters.

What is the current status of trial NCT05699460?

This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2022-09-29. Estimated completion is 2025-11.

What conditions does trial NCT05699460 study?

This clinical trial studies the following conditions: Parkinson's Disease, Multiple System Atrophy, Multiple System Atrophy, Parkinson Variant.

What interventions are being tested in trial NCT05699460?

The interventions under investigation include: This is an observational study. (OTHER).

Who is sponsoring clinical trial NCT05699460?

This trial is sponsored by AskBio, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05699460 being conducted?

This trial has 11 study locations across California, Florida, Massachusetts, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Multiple System Atrophy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.